Tuo Wang

277, Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

CXCL8 Enhances Malignancy of GBM via TNFα-NFκB Mediated Suppression of Ferroptosis.

Journal: Applied biochemistry and biotechnology

Published: May 21, 2026

Multimodal Localization Using Smartphone Augmented Reality Combined with Brain Surface Morphology for Surgical Removal of Supratentorial Lesions.

Multimodal Localization Using Smartphone Augmented Reality Combined with Brain Surface Morphology for Surgical Removal of Supratentorial Lesions.

Journal: World neurosurgery

Published: July 23, 2025

SDF2 promotes glioma progression via GRP78‑mediated ERAD and copper homeostasis disruption.

SDF2 promotes glioma progression via GRP78‑mediated ERAD and copper homeostasis disruption.

Journal: International journal of molecular medicine

Published: March 10, 2025

TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription.

TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription.

Journal: Current cancer drug targets

Published: October 29, 2024

Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome.

Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome.

Journal: World journal of surgical oncology

Published: March 20, 2024

CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.

CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.

Journal: Oncology letters

Published: September 19, 2023

MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/AKT/mTOR signaling.

MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/AKT/mTOR signaling.

Journal: CNS neuroscience & therapeutics

Published: March 26, 2023

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways.

CXCL5 promotes tumorigenesis and angiogenesis of glioblastoma via JAK-STAT/NF-κb signaling pathways.

Journal: Molecular biology reports

Published: March 14, 2023

MiR-320b aberrant expression enhances the radioresistance of human glioma via upregulated expression of ALDH1A3.

MiR-320b aberrant expression enhances the radioresistance of human glioma via upregulated expression of ALDH1A3.

Journal: Aging

Published: September 15, 2022

A rare case of spindle cell neoplasm with NTRK-fusion in central nervous system.

A rare case of spindle cell neoplasm with NTRK-fusion in central nervous system.

Journal: Pathology international

Published: June 22, 2022

MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.

MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.

Journal: Cell cycle (Georgetown, Tex.)

Published: October 18, 2021

Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.

Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 24, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026